Humoral autoimmunity to cartilage in rheumatoid arthritis?

Trends in EU regulatory assessment of oncology medicines.

ESMO open·2026

The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer.

ESMO open·2022

The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation.

ESMO open·2021

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.

ESMO open·2021

The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements.

ESMO open·2021

The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer.

ESMO open·2021

Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness.

Agents and actions·1994

Diamine oxidase in relation to diamine and polyamine metabolism.

Agents and actions·1994

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Journal of cutaneous medicine and surgery·2026

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: How to manage thyroid diseases: from autoimmunity to malignancy Special Issue.

Drugs in context·2026

Gut microbiome dysbiosis is associated with aldosterone overproduction in idiopathic hyperaldosteronism.

iScience·2026

Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.

Materials today. Bio·2026

SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN.

Frontiers in immunology·2026

How to manage autoimmune hyperthyroidism (Graves' disease): from differential diagnosis to emerging immunological therapies.

Drugs in context·2026

Related Experiment Videos

Humoral autoimmunity to cartilage in rheumatoid arthritis?

Related Concept Videos

Trends in EU regulatory assessment of oncology medicines.

The European Medicines Agency review of sacituzumab govitecan for the treatment of triple-negative breast cancer.

The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutation.

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient colorectal cancer.

The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusions and adult patients with non-small-cell lung cancer harbouring ROS1 rearrangements.

The EMA review of trastuzumab emtansine (T-DM1) for the adjuvant treatment of adult patients with HER2-positive early breast cancer.

Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness.

Diamine oxidase in relation to diamine and polyamine metabolism.

Immune-Cell Profiling Identifies a Defective Macrophage-Maresin 1 Resolution Axis as a Pathogenic Driver and Therapeutic Target in Vitiligo and Canities.

Management of thyroid disorders: from autoimmunity to malignancy - novel insights from precision medicine: How to manage thyroid diseases: from autoimmunity to malignancy Special Issue.

Gut microbiome dysbiosis is associated with aldosterone overproduction in idiopathic hyperaldosteronism.

Physicochemically-guided immunomodulatory biomaterials for regulating immune responses in rheumatoid arthritis.

SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN.

How to manage autoimmune hyperthyroidism (Graves' disease): from differential diagnosis to emerging immunological therapies.

Related Experiment Videos

Humoral autoimmunity to cartilage in rheumatoid arthritis?

Related Concept Videos

Related Articles